Dr. Jörg Taubel will be attending the ESC Congress 2024, held from 30th August to 2nd September in London and online. This event is the world’s leading gathering for cardiovascular professionals, bringing together experts to explore ground breaking research, innovative technologies, and collaborative efforts aimed at reducing the burden of cardiovascular disease.

The ESC Congress 2024 will feature a comprehensive programme, including sessions on the latest advancements in cardiovascular medicine, discussions on clinical practice guidelines, and presentations of cutting-edge research. Attendees will include cardiologists, researchers, healthcare professionals, and industry leaders dedicated to advancing cardiovascular health and improving patient outcomes.

To find out more, click here.

Latest news

Richmond Appoints Lisa Campbell as Director of Regulatory Strategy

April 23, 2025
Richmond Pharmacology is pleased to announce the appointment of Lisa Campbell as Director of Regulatory Strategy
Read more

Von Willebrand Disease Trial – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol

April 2, 2025
Richmond has completed dosing the first cohort of patients in Velora Pioneer, a phase 1/2 clinical trial investigating Hemab...
Read more

Events

Swiss Biotech Day 2025

5–6 May 2025
Richmond Pharmacology is pleased to confirm our participation at Swiss Biotech Day 2025
View event